Mycophenolate Sodium Tablets are widely used in the medical industry for treating the prophylaxis of organ rejection in patients. Based in Delhi, we are involved in manufacturing, supplying and exporting Mycophenolate Sodium Tablets. The Mycophenolate Sodium Tablets that we offer are formulated under hygienic conditions using high grade chemical compounds.

Indications : For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Dosage :

• Adults : The recommended doses is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, one hour before or two hours after food intake.
• Pediatrics : Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Patients with a BSA of 1.19 to 1.58 m² may be dosed either with three 180 mg tablets or one 180 mg plus one 360 mg tablet twice daily (1080 mg daily dose). 

Dosage Adjustment :

• Renal Impairment : Not required.
• Hepatic Impairment : May be required in renal patients with some hepatic diseases.

Available Packing :

• 6 Strips of 10 Tablets of 180 Mg
• 6 Strips of 10 Tablets of 360 Mg

Mycophenolate Sodium Tablets are widely used in the medical industry for treating the prophylaxis of organ rejection in patients. Based in Delhi, we are involved in manufacturing, supplying and exporting Mycophenolate Sodium Tablets. The Mycophenolate Sodium Tablets that we offer are formulated under hygienic conditions using high grade chemical compounds.

Indications : For the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants.
Dosage :

• Adults : The recommended doses is 720 mg administered twice daily (1440 mg total daily dose) on an empty stomach, one hour before or two hours after food intake.
• Pediatrics : Based on a pharmacokinetic study conducted in stable renal pediatric transplant patients, the recommended dose in stable pediatric patients is 400 mg/m² body surface area (BSA) administered twice daily (up to a maximum dose of 720 mg administered twice daily). Patients with a BSA of 1.19 to 1.58 m² may be dosed either with three 180 mg tablets or one 180 mg plus one 360 mg tablet twice daily (1080 mg daily dose). 

Dosage Adjustment :

• Renal Impairment : Not required.
• Hepatic Impairment : May be required in renal patients with some hepatic diseases.

Available Packing :

• 6 Strips of 10 Tablets of 180 Mg
• 6 Strips of 10 Tablets of 360 Mg